{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:36:16Z","timestamp":1792290976284,"version":"4.4.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s40122-025-00778-8","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T08:55:39Z","timestamp":1758272139000},"page":"1629-1645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neurotransmitter Imbalance in Cluster Headache: A Systematic Review of Mechanisms and Therapeutic Targets"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4137-5039","authenticated-orcid":false,"given":"Lanfranco","family":"Pellesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2302-6273","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6556-4128","authenticated-orcid":false,"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"778_CR1","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1474-4422(24)00143-1","volume":"23","author":"AS Petersen","year":"2024","unstructured":"Petersen AS, Lund N, Goadsby PJ, et al. Recent advances in diagnosing, managing, and understanding the pathophysiology of cluster headache. Lancet Neurol. 2024;23:712\u201324.","journal-title":"Lancet Neurol"},{"key":"778_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s10194-018-0911-x","volume":"19","author":"YJ Choi","year":"2018","unstructured":"Choi YJ, Kim BK, Chung PW, et al. Impact of cluster headache on employment status and job burden: a prospective cross-sectional multicenter study. J Headache Pain. 2018;19:78.","journal-title":"J Headache Pain"},{"key":"778_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s10194-024-01838-8","volume":"25","author":"K Kamm","year":"2024","unstructured":"Kamm K, Straube A, Burish M, Ruscheweyh R. Disability in cluster headache is more than attack frequency\u2014results from and validation of the English version of the Cluster Headache Impact Questionnaire (CHIQ). J Headache Pain. 2024;25:128.","journal-title":"J Headache Pain"},{"key":"778_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s10194-024-01738-x","volume":"25","author":"K Hagen","year":"2024","unstructured":"Hagen K. One-year prevalence of cluster headache, hemicrania continua, paroxysmal hemicrania and SUNCT in Norway: a population-based nationwide registry study. J Headache Pain. 2024;25:30.","journal-title":"J Headache Pain"},{"key":"778_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/B978-0-12-819973-2.00027-7","volume":"182","author":"M Leone","year":"2021","unstructured":"Leone M, Ferraro S, Proietti CA. The neurobiology of cluster headache. Handb Clin Neurol. 2021;182:401\u201314.","journal-title":"Handb Clin Neurol"},{"key":"778_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10194-009-0112-8","volume":"10","author":"P Tfelt-Hansen","year":"2009","unstructured":"Tfelt-Hansen P, Le H. Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review. J Headache Pain. 2009;10:137\u201343.","journal-title":"J Headache Pain"},{"key":"778_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s10194-016-0705-y","volume":"17","author":"E Bacchelli","year":"2016","unstructured":"Bacchelli E, Cainazzo MM, Cameli C, et al. A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants. J Headache Pain. 2016;17:114.","journal-title":"J Headache Pain"},{"key":"778_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s10194-023-01660-8","volume":"24","author":"NLT Lund","year":"2023","unstructured":"Lund NLT, Petersen AS, Fronczek R, et al. Current treatment options for cluster headache: limitations and the unmet need for better and specific treatments-a consensus article. J Headache Pain. 2023;24:121.","journal-title":"J Headache Pain"},{"key":"778_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/head.14641","volume":"64","author":"MK S\u00f8borg","year":"2024","unstructured":"S\u00f8borg MK, Jensen RH, Barloese M, Petersen AS. Biomarkers in cluster headache: a systematic review. Headache. 2024;64:98\u2013116.","journal-title":"Headache"},{"key":"778_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"778_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1046\/j.1468-2982.1990.1001039.x","volume":"10","author":"M Nicolodi","year":"1990","unstructured":"Nicolodi M, Del Bianco E. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache. Cephalalgia. 1990;10:39\u201350.","journal-title":"Cephalalgia"},{"key":"778_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/brain\/117.3.427","volume":"117","author":"PJ Goadsby","year":"1994","unstructured":"Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain. 1994;117:427\u201334.","journal-title":"Brain"},{"key":"778_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0304-3959(94)00097-X","volume":"60","author":"M Fanciullacci","year":"1995","unstructured":"Fanciullacci M, Alessandri M, Figini M, Geppetti P, Michelacci S. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain. 1995;60:119\u201323.","journal-title":"Pain"},{"key":"778_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/brain\/120.2.283","volume":"120","author":"M Fanciullacci","year":"1997","unstructured":"Fanciullacci M, Alessandri M, Sicuteri R, Marabini S. Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients. Brain. 1997;120:283\u20138.","journal-title":"Brain"},{"key":"778_CR15","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamaneurol.2018.1675","volume":"75","author":"ALH Vollesen","year":"2018","unstructured":"Vollesen ALH, Snoer A, Beske RP, et al. Effect of infusion of calcitonin gene-related peptide on cluster headache attacks: a randomized clinical trial. JAMA Neurol. 2018;75:1187\u201397.","journal-title":"JAMA Neurol"},{"key":"778_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/0333102419837154","volume":"39","author":"A Snoer","year":"2019","unstructured":"Snoer A, Vollesen ALH, Beske RP, et al. Calcitonin-gene related peptide and disease activity in cluster headache. Cephalalgia. 2019;39:575\u201384.","journal-title":"Cephalalgia"},{"key":"778_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/0333102414539057","volume":"35","author":"L Neeb","year":"2015","unstructured":"Neeb L, Anders L, Euskirchen P, Hoffmann J, Israel H, Reuter U. Corticosteroids alter CGRP and melatonin release in cluster headache episodes. Cephalalgia. 2015;35:317\u201326.","journal-title":"Cephalalgia"},{"key":"778_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/0333102420949858","volume":"41","author":"K Kamm","year":"2021","unstructured":"Kamm K, Straube A, Ruscheweyh R. Baseline tear fluid CGRP is elevated in active cluster headache patients as long as they have not taken attack abortive medication. Cephalalgia. 2021;41:69\u201377.","journal-title":"Cephalalgia"},{"key":"778_CR19","doi-asserted-by":"publisher","first-page":"333102423122397","DOI":"10.1177\/03331024231223970","volume":"44","author":"AS Petersen","year":"2024","unstructured":"Petersen AS, Lund N, Me\u00dflinger K, et al. Reduced plasma calcitonin gene-related peptide level identified in cluster headache: a prospective and controlled study. Cephalalgia. 2024;44:3331024231223970.","journal-title":"Cephalalgia"},{"key":"778_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1046\/j.1468-2982.1985.0503143.x","volume":"5","author":"F Sicuteri","year":"1985","unstructured":"Sicuteri F, Fanciullacci M, Geppetti P, Renzi D, Caleri D, Spillantini MG. Substance P mechanism in cluster headache: evaluation in plasma and cerebrospinal fluid. Cephalalgia. 1985;5:143\u20139.","journal-title":"Cephalalgia"},{"key":"778_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1526-4610.1980.hed2006294.x","volume":"20","author":"B Anselmi","year":"1980","unstructured":"Anselmi B, Baldi E, Casacci F, Salmon S. Endogenous opioids in cerebrospinal fluid and blood in idiopathic headache sufferers. Headache. 1980;20:294\u20139.","journal-title":"Headache"},{"key":"778_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1526-4610.1989.hed2908494.x","volume":"29","author":"JE Hardebo","year":"1989","unstructured":"Hardebo JE, Ekman R, Eriksson M. Low CSF met-enkephalin levels in cluster headache are elevated by acupuncture. Headache. 1989;29:494\u20137.","journal-title":"Headache"},{"key":"778_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1046\/j.1468-2982.1993.1306413.x","volume":"13","author":"M Leone","year":"1993","unstructured":"Leone M, Sacerdote P, D\u2019Amico D, Panerai AE, Bussone G. Beta-endorphin levels are reduced in peripheral blood mononuclear cells of cluster headache patients. Cephalalgia. 1993;13:413\u20136.","journal-title":"Cephalalgia"},{"key":"778_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1526-4610.1994.hed3405257.x","volume":"34","author":"ML Figuerola","year":"1994","unstructured":"Figuerola ML, Levin G, Leston J, Barontini M. Opioid and sympathetic nervous system activity in cluster headache under verapamil or prednisone treatment. Headache. 1994;34:257\u201360.","journal-title":"Headache"},{"key":"778_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1046\/j.1526-4610.1996.3610603.x","volume":"36","author":"R Franceschini","year":"1996","unstructured":"Franceschini R, Leandri M, Gianelli MV, et al. Evaluation of beta-endorphin secretion in patients suffering from episodic cluster headache. Headache. 1996;36:603\u20137.","journal-title":"Headache"},{"key":"778_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/jama.1941.02820050021005","volume":"116","author":"BT Horton","year":"1941","unstructured":"Horton BT. The use of histamine in the treatment of specific types of headaches. JAMA. 1941;116:377\u201383.","journal-title":"JAMA"},{"key":"778_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1600-0404.1970.tb05797.x","volume":"46","author":"O Sjaastad","year":"1970","unstructured":"Sjaastad O, Sjaastad OV. The histaminuria in vascular headache. Acta Neurol Scand. 1970;46:331\u201342.","journal-title":"Acta Neurol Scand"},{"key":"778_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/archneur.1971.00490030051005","volume":"25","author":"M Anthony","year":"1971","unstructured":"Anthony M, Lance JW. Histamine and serotonin in cluster headache. Arch Neurol. 1971;25:225\u201331.","journal-title":"Arch Neurol"},{"key":"778_CR29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1526-4610.1979.hed1906309.x","volume":"19","author":"JL Medina","year":"1979","unstructured":"Medina JL, Diamond S, Fareed J. The nature of cluster headache. Headache. 1979;19:309\u201322.","journal-title":"Headache"},{"key":"778_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1046\/j.1468-2982.1985.0501045.x","volume":"5","author":"E Waldenlind","year":"1985","unstructured":"Waldenlind E, Ross SB, S\u00e4\u00e4f J, Ekbom K, Wetterberg L. Concentration and uptake of 5-hydroxytryptamine in platelets from cluster headache and migraine patients. Cephalalgia. 1985;5:45\u201354.","journal-title":"Cephalalgia"},{"key":"778_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1468-2982.1998.1802094.x","volume":"18","author":"G D\u2019Andrea","year":"1998","unstructured":"D\u2019Andrea G, Granella F, Alecci M, Manzoni GC. Serotonin metabolism in cluster headache. Cephalalgia. 1998;18:94\u20136.","journal-title":"Cephalalgia"},{"key":"778_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1468-2982.2005.01006.x","volume":"26","author":"F Blandini","year":"2006","unstructured":"Blandini F, Rinaldi L, Tassorelli C, et al. Peripheral levels of BDNF and NGF in primary headaches. Cephalalgia. 2006;26:136\u201342.","journal-title":"Cephalalgia"},{"key":"778_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10072-017-2862-4","volume":"38","author":"G D\u2019Andrea","year":"2017","unstructured":"D\u2019Andrea G, Bussone G, Di Fiore P, et al. Pathogenesis of chronic cluster headache and bouts: role of tryptamine, arginine metabolism and \u03b11-agonists. Neurol Sci. 2017;38:37\u201343.","journal-title":"Neurol Sci"},{"key":"778_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s10194-016-0620-2","volume":"17","author":"M Curto","year":"2015","unstructured":"Curto M, Lionetto L, Negro A, et al. Altered serum levels of kynurenine metabolites in patients affected by cluster headache. J Headache Pain. 2015;17:27.","journal-title":"J Headache Pain"},{"key":"778_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1046\/j.1468-2982.1991.1104197.x","volume":"11","author":"G D\u2019Andrea","year":"1991","unstructured":"D\u2019Andrea G, Cananzi AR, Joseph R, et al. Platelet glycine, glutamate and aspartate in primary headache. Cephalalgia. 1991;11:197\u2013200.","journal-title":"Cephalalgia"},{"key":"778_CR36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1001\/archneur.1968.00480050057005","volume":"19","author":"K Ekbom","year":"1968","unstructured":"Ekbom K. Nitroglycerin as a provocative agent in cluster headache. Arch Neurol. 1968;19:487\u201393.","journal-title":"Arch Neurol"},{"key":"778_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1046\/j.1468-2982.1990.1002071.x","volume":"10","author":"A Bogucki","year":"1990","unstructured":"Bogucki A. Studies on nitroglycerin and histamine provoked cluster headache attacks. Cephalalgia. 1990;10:71\u20135.","journal-title":"Cephalalgia"},{"key":"778_CR38","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1007\/PL00014993","volume":"20","author":"D D\u2019Amico","year":"1999","unstructured":"D\u2019Amico D, Leone M, Ferraris A, et al. Role of nitric oxide in cluster headache. Ital J Neurol Sci. 1999;20:S25\u20137.","journal-title":"Ital J Neurol Sci"},{"key":"778_CR39","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/jnnp.55.4.308","volume":"55","author":"G D\u2019Andrea","year":"1992","unstructured":"D\u2019Andrea G, Cananzi AR, Morra M, et al. Platelet catecholamines in cluster headache. J Neurol Neurosurg Psychiatry. 1992;55:308\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"778_CR40","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1097\/00001756-199605170-00001","volume":"7","author":"M Strittmatter","year":"1996","unstructured":"Strittmatter M, Hamann GF, Grauer M, et al. Altered activity of the sympathetic nervous system and changes in the balance of hypophyseal, pituitary and adrenal hormones in patients with cluster headache. NeuroReport. 1996;7:1229\u201334.","journal-title":"NeuroReport"},{"key":"778_CR41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1526-4610.2006.00407.x","volume":"46","author":"G D\u2019Andrea","year":"2006","unstructured":"D\u2019Andrea G, Granella F, Perini F, Farruggio A, Leone M, Bussone G. Platelet levels of dopamine are increased in migraine and cluster headache. Headache. 2006;46:585\u201391.","journal-title":"Headache"},{"key":"778_CR42","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/j.1468-2982.2007.01366.x","volume":"27","author":"EL Meyer","year":"2007","unstructured":"Meyer EL, Marcus C, Waldenlind E. Nocturnal secretion of growth hormone, noradrenaline, cortisol and insulin in cluster headache remission. Cephalalgia. 2007;27:912\u20139.","journal-title":"Cephalalgia"},{"key":"778_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/0333102416640502","volume":"37","author":"G D\u2019Andrea","year":"2017","unstructured":"D\u2019Andrea G, Leone M, Bussone G, et al. Abnormal tyrosine metabolism in chronic cluster headache. Cephalalgia. 2017;37:148\u201353.","journal-title":"Cephalalgia"},{"key":"778_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s10194-016-0660-7","volume":"17","author":"B Tuka","year":"2016","unstructured":"Tuka B, Szab\u00f3 N, T\u00f3th E, et al. Release of PACAP-38 in episodic cluster headache patients \u2013 an exploratory study. J Headache Pain. 2016;17:69.","journal-title":"J Headache Pain"},{"key":"778_CR45","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1177\/0333102420940689","volume":"40","author":"ALH Vollesen","year":"2020","unstructured":"Vollesen ALH, Snoer A, Chaudhry B, et al. The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache. Cephalalgia. 2020;40:1474\u201388.","journal-title":"Cephalalgia"},{"key":"778_CR46","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/03331024211056248","volume":"42","author":"L Pellesi","year":"2022","unstructured":"Pellesi L, Chaudhry BA, Vollesen ALH, et al. PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation. Cephalalgia. 2022;42:687\u201395.","journal-title":"Cephalalgia"},{"key":"778_CR47","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1177\/0333102411403634","volume":"31","author":"S Cevoli","year":"2011","unstructured":"Cevoli S, Pizza F, Grimaldi D, et al. Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache. Cephalalgia. 2011;31:973\u20136.","journal-title":"Cephalalgia"},{"key":"778_CR48","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1177\/0333102414562971","volume":"35","author":"M Barloese","year":"2015","unstructured":"Barloese M, Jennum P, Lund N, Knudsen S, Gammeltoft S, Jensen R. Reduced CSF hypocretin-1 levels are associated with cluster headache. Cephalalgia. 2015;35:869\u201376.","journal-title":"Cephalalgia"},{"key":"778_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s10194-023-01711-0","volume":"25","author":"S Ferraro","year":"2024","unstructured":"Ferraro S, Nigri A, Bruzzone MG, et al. Involvement of the ipsilateral-to-the-pain anterior-superior hypothalamic subunit in chronic cluster headache. J Headache Pain. 2024;25:7.","journal-title":"J Headache Pain"},{"key":"778_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s10194-025-02017-z","volume":"26","author":"S Ferraro","year":"2025","unstructured":"Ferraro S, Demichelis G, Medina Carrion JP, et al. Dysfunctional mesocorticolimbic circuitry in cluster headache. J Headache Pain. 2025;26:121.","journal-title":"J Headache Pain"},{"key":"778_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s10194-024-01920-1","volume":"26","author":"C Abagnale","year":"2025","unstructured":"Abagnale C, Di Renzo A, Giuliani G, et al. MRI-based analysis of the microstructure of the thalamus and hypothalamus and functional connectivity between cortical networks in episodic cluster headache. J Headache Pain. 2025;26:12.","journal-title":"J Headache Pain"},{"key":"778_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s42399-021-01083-z","volume":"4","author":"H Pohl","year":"2022","unstructured":"Pohl H, Gantenbein AR, Sandor PS. Cluster headache and the comprehension paradox. SN Compr Clin Med. 2022;4:32.","journal-title":"SN Compr Clin Med"},{"key":"778_CR53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s10194-025-02023-1","volume":"26","author":"O Grodzka","year":"2025","unstructured":"Grodzka O, \u0141agowski W, Eyileten C, Domitrz I. Biomarkers in headaches as a potential solution to simplify differential diagnosis of primary headache disorders: a systematic review. J Headache Pain. 2025;26:73.","journal-title":"J Headache Pain"},{"key":"778_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10194-025-02001-7","volume":"26","author":"EK Van Obberghen","year":"2025","unstructured":"Van Obberghen EK, Fabre R, Lanteri-Minet M. Cluster headache diagnostic delay and its predictors: a systematic review with a meta-analysis. J Headache Pain. 2025;26:71.","journal-title":"J Headache Pain"},{"key":"778_CR55","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10194-010-0232-1","volume":"11","author":"PC Tfelt-Hansen","year":"2010","unstructured":"Tfelt-Hansen PC. Verisimilitude (or \u201ctruthlikeness\u201d) as an alternative to pro and cons: migraine and cluster headache mechanisms. J Headache Pain. 2010;11:379\u201389.","journal-title":"J Headache Pain"},{"key":"778_CR56","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11916-022-01070-6","volume":"26","author":"ST Chen","year":"2022","unstructured":"Chen ST, Wu JW. CGRP-targeted therapy for episodic and chronic cluster headache. Curr Pain Headache Rep. 2022;26:667\u201375.","journal-title":"Curr Pain Headache Rep"},{"key":"778_CR57","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa1813440","volume":"381","author":"PJ Goadsby","year":"2019","unstructured":"Goadsby PJ, Dodick DW, Leone M, et al. Trial of galcanezumab in prevention of episodic cluster headache. N Engl J Med. 2019;381:132\u201341.","journal-title":"N Engl J Med"},{"key":"778_CR58","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jamaneurol.2025.1317","volume":"82","author":"RH Jensen","year":"2025","unstructured":"Jensen RH, Tassorelli C, Tepper SJ, et al. Efficacy and safety of eptinezumab in episodic cluster headache: a randomized clinical trial. JAMA Neurol. 2025;82:706\u201314.","journal-title":"JAMA Neurol"},{"key":"778_CR59","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.16318","volume":"8","author":"J Mecklenburg","year":"2025","unstructured":"Mecklenburg J, Gaul C, Fitzek M, et al. Erenumab for chronic cluster headache: a randomized clinical trial. JAMA Netw Open. 2025;8:e2516318.","journal-title":"JAMA Netw Open"},{"key":"778_CR60","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s42399-023-01452-w","volume":"5","author":"DD Mitsikostas","year":"2023","unstructured":"Mitsikostas DD, Alexoudi A, Arvaniti C, et al. Hellenic headache society recommendations for the use of monoclonal antibodies targeting the calcitonin gene-related peptide pathway for the prevention of migraine and cluster headache \u2013 2023 update. SN Compr Clin Med. 2023;5:118.","journal-title":"SN Compr Clin Med"},{"key":"778_CR61","doi-asserted-by":"publisher","unstructured":"Garelja ML, Rees TA, Hay DL. Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assays. Headache. 2025 Aug 7. https:\/\/doi.org\/10.1111\/head.15011. Online ahead of print.","DOI":"10.1111\/head.15011"},{"issue":"1","key":"778_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s10194-025-01959-8","volume":"26","author":"L Pellesi","year":"2025","unstructured":"Pellesi L, Edvinsson L. Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP success. J Headache Pain. 2025;26(1):22.","journal-title":"J Headache Pain"},{"key":"778_CR63","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/head.13473","volume":"59","author":"SM Pearson","year":"2019","unstructured":"Pearson SM, Burish MJ, Shapiro RE, Yan Y, Schor LI. Effectiveness of oxygen and other acute treatments for cluster headache: results from the Cluster Headache Questionnaire, an international survey. Headache. 2019;59:235\u201349.","journal-title":"Headache"},{"key":"778_CR64","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10194-006-0296-0","volume":"7","author":"M Fanciullacci","year":"2006","unstructured":"Fanciullacci M. When cluster headache was called histaminic cephalalgia (Horton\u2019s headache). J Headache Pain. 2006;7:231\u20134.","journal-title":"J Headache Pain"},{"key":"778_CR65","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/bmj.2.6035.585-a","volume":"2","author":"T Veger","year":"1976","unstructured":"Veger T, Russell D, Sjaastad O. Histamine H2 antagonists and cluster headache. Br Med J. 1976;2:585.","journal-title":"Br Med J"},{"key":"778_CR66","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/jnnp.42.7.668","volume":"42","author":"D Russell","year":"1979","unstructured":"Russell D. Cluster headache: trial of a combined histamine H1 and H2 antagonist treatment. J Neurol Neurosurg Psychiatry. 1979;42:668\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"778_CR67","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s10194-019-0984-1","volume":"20","author":"J Worm","year":"2019","unstructured":"Worm J, Falkenberg K, Olesen J. Histamine and migraine revisited: mechanisms and possible drug targets. J Headache Pain. 2019;20:30.","journal-title":"J Headache Pain"},{"key":"778_CR68","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10194-007-0373-z","volume":"8","author":"P Tfelt-Hansen","year":"2007","unstructured":"Tfelt-Hansen P. Acute pharmacotherapy of migraine, tension-type headache, and cluster headache. J Headache Pain. 2007;8:127\u201334.","journal-title":"J Headache Pain"},{"key":"778_CR69","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.18543","volume":"4","author":"L Pellesi","year":"2021","unstructured":"Pellesi L, Al-Karagholi MA, De Icco R, et al. Effect of vasoactive intestinal polypeptide on development of migraine headaches: a randomized clinical trial. JAMA Netw Open. 2021;4:e2118543.","journal-title":"JAMA Netw Open"},{"key":"778_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/14728214.2024.2317778","volume":"29","author":"L Pellesi","year":"2024","unstructured":"Pellesi L, Ashina M, Martelletti P. Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention. Expert Opin Emerg Drugs. 2024;29:57\u201364.","journal-title":"Expert Opin Emerg Drugs"},{"key":"778_CR71","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa2314577","volume":"391","author":"M Ashina","year":"2024","unstructured":"Ashina M, Phul R, Khodaie M, L\u00f6f E, Florea I. A monoclonal antibody to PACAP for migraine prevention. N Engl J Med. 2024;391:800\u20139.","journal-title":"N Engl J Med"},{"key":"778_CR72","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1007\/s12325-025-03166-y","volume":"42","author":"L Pellesi","year":"2025","unstructured":"Pellesi L, Chalmer MA, Guo S, Do TP, Xiao Z, Martelletti P. Targeting PACAP: beyond migraine to cluster, menstrual, and post-traumatic headaches. Adv Ther. 2025;42:2078\u201388.","journal-title":"Adv Ther"},{"issue":"3","key":"778_CR73","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s10194-007-0383-x","volume":"8","author":"I Rainero","year":"2007","unstructured":"Rainero I, Rubino E, Valfr\u00e8 W, et al. Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis. J Headache Pain. 2007;8(3):152\u20136.","journal-title":"J Headache Pain"},{"key":"778_CR74","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1177\/0333102414557839","volume":"35","author":"CM Weller","year":"2015","unstructured":"Weller CM, Wilbrink LA, Houwing-Duistermaat JJ, et al. Cluster headache and the hypocretin receptor 2 reconsidered: a genetic association study and meta-analysis. Cephalalgia. 2015;35:741\u20137.","journal-title":"Cephalalgia"},{"key":"778_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-017-0831-1","volume":"19","author":"Z Fan","year":"2018","unstructured":"Fan Z, Hou L, Wan D, Ao R, Zhao D, Yu S. Genetic association of HCRTR2, ADH4 and CLOCK genes with cluster headache: a Chinese population-based case-control study. J Headache Pain. 2018;19:1.","journal-title":"J Headache Pain"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00778-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-025-00778-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00778-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:05:28Z","timestamp":1763640328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-025-00778-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["778"],"URL":"https:\/\/doi.org\/10.1007\/s40122-025-00778-8","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lanfranco Pellesi serves as member of the Editorial Board of\n                      The Journal of Headache and Pain\n                      ,\n                      BMC Neurology\n                      ,\n                      Pain Research and Management\n                      ,\n                      European Journal of Medical Research\n                      , and\n                      Brain Conflux\n                      . In addition, Lanfranco Pellesi is Editor-in-Training for\n                      Clinical and Translational Science\n                      . Wei Wang serves as member of the Editorial Board of\n                      The Journal of Headache and Pain\n                      and\n                      SN Comprehensive Clinical Medicine\n                      . Paolo Martelletti is the Editor-in-Chief of\n                      The Journal of Headache and Pain\n                      and of\n                      SN Comprehensive Clinical Medicine\n                      . Wei Wang and Paolo Martelletti are members of the Editorial Board of\n                      Pain and Therapy\n                      . Wei Wang and Paolo Martelletti have not been involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Anas Mohammad declares that he has no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}